Ethtry PLC (ETHY.AQ)
Aquis AQSE · GBp · Healthcare · Biotechnology
£0.14 (+0.00%) as of
Key statistics
- Dividend yield
- 0.00%
- 52-week range
- 0.0011 – 0.2100
- Beta
- 0.39
- Profit margin
- 0.00%
- Volume
- 15.28M
About Ethtry PLC
Ethtry PLC is a venture capital firm specializing in early stage investments. It focuses on investing in businesses and companies in healthcare, life sciences, breakthrough technologies, the service technology sectors, communication services, quantum technologies, artificial intelligence, data centres, energy storage, web3 including products related to social or life enhancement. The firm prefers to take a controlling stake in its portfolio companies. Ethtry PLC was incorporated on 16 October 2007 and is based in London, United Kingdom. Igraine Plc operates as a subsidiary of St Gallen Capital Limited.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- London, United Kingdom
- Employees
- 3
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.
Related stocks
- First Trust Bloomberg Nuclear Power UCITS ETF Class A ACCU (RCTU.L)
- WAG Payment Solutions PLC (EWGL.XC)
- Vend Marketplaces ASA (VENDO.XC)
- CRISM THERAPEUTICS CORPORATION (CRTX.L)
- MEDIAZEST PLC ORD 0.01P (MDZ.L)
- Law Debenture Corp PLC/fund (LWDBL.XC)
- PUBLIC POLICY HOLDING COMPANY, (PPHC.L)
- STORA ENSO OYJ STORA ENSO SERIE (0CXC.IL)